The role of TNFα in adipocyte metabolism

Seminars in Cell and Developmental Biology

Volumn 10, Issue 1, 1999, Pages 19-29

  Sethi, Jaswinder K ^b   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Adipose tissue; Glucose metabolism; Insulin resistance; Lipid metabolism; Tumor necrosis factor (TNF )

Indexed keywords

LEPTIN; LIGAND; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADIPOCYTE; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; REVIEW;

ADIPOCYTES; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; HUMANS; INSULIN RESISTANCE; LEPTIN; LIGANDS; LIPID METABOLISM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BIOSYNTHESIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033073540     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.1998.0273     Document Type: Article

References (132)

1. Flier JS (1995) The adipocyte: storage depot or node on the energy information superhighway? Cell 80:15-18
2. Mohamed-Ali V, Pinkney JH, Coppack SW (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes 22:1145-1158
3. Beutler B (1995) TNF, immunity and inflammatory disease: lessons of the past decade. J Invest Med 43:227-235
4. Decoster E, Vanhaesebroeck B, Vandenabeele P, Grooten J, Fiers W (1995) Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem 270:18473-18478
5. Xu H, Sethi JK, Uysal KT, Wiesbrock SM, Scheja L, Hotamisligil GS (1998) The transmembrane form of TNF-alpha inhibits adipogenesis via TNFR1. (submitted)
6. Kriegler M, Ferez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53
7. Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol Today 13:151-153
8. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962
9. Tartaglia LA, Pennica D, Goeddel DV (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548
10. Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316
11. van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF (1992) Tumour necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 89:4845-4849
12. Aderka D, Engelmann H, Wallach D. (1993) Soluble tumor necrosis factor receptors in health and disease, in: Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance (Fiers W, Buurman WA, eds.) pp. 191-198. S. Karger AG, Basel
13. Liabakk NB, Sundan A, Waage A, Brockhaus M, Loetcher H, Lesslauer W, Espevik T (1991) Development of immunoassays for the detection of soluble tumour necrosis factor receptors. J Immunol Methods 141:237-243
14. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM (1997) Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455
15. Tsigos C, Kyrou I, Economidou C, Tsapogas P, Kantzos N, Mantas P, Katsilambros N (1998) Elevated circulating tumor necrosis factor alpha receptor 1 and 2 (TNFR1, TNFR2) concentrations in human obesity. Int J Obes 21:S9
16. Ramsay TG (1996) Fat cells. Endocrinol Metab Clin N Am 25:847-870
17. Carbo N, Costelli P, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Baccino FM, Argiles JM (1994) Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a cachectic tumor model. Clin Sci 87:349-355
18. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94:1543-1549
19. Lopezsoriano FJ, Bagby GJ, Williamson DH, Argiles JM (1997) Anti-TNF treatment does not reverse the abnormalities in Lipid metabolism of the obese Zucker rat. Am J Physiol 35:E656-E660
20. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614
21. Ventre J, Doebber T, Wu M, Macnaul K, Stevens K, Pasparakis M, Kollias G, Moller DE (1997) Targeted disruption of the tumor necrosis factor-alpha gene - metabolic consequences in obese and non-obese mice. Diabetes 46:1526-1531
22. Kawakami M, Murase T, Ogawa H, Ishibashi S, Mori N, Takaku F, Shibata S (1987) Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem 101:331-338
23. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grunfeld C (1992) Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 130:10-16
24. Green A, Dobias SB, Walters DJ, Brasier AR (1994) Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormonesensitive lipase. Endocrinology 134:2581-2588
25. Hauner H, Petruschke T, Russ M, Eckel J (1995) Effects of tumour necrosis factor alpha on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38:764-771
26. Souza SC, Yamamoto MT, Franciosa MD, Lien P, Greenberg AS (1998) BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes 47:691-695
27. Peraldi P, Xu M, Spiegelman BM (1997) Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. J Clin Invest 100:1863-1869
28. Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM (1997) TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46:1678-1683
29. Comelius P, Enerback S, Bjursell G, Olivecrona T, Pekala PH (1988) Regulation of lipoprotein lipase mRNA content in 3T3-LI cells by tumor necrosis factor. Biochem J 249:765-769
30. Semb H, Peterson J, Tavernier J, Olivecrona T (1987) Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 262:8390-8394
31. Kern PA (1988) Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes. J Lipid Res 29:909-914
32. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C (1998) Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 37:E210-E217
33. Pape ME, Kim KH (1988) Effect of tumor necrosis factor on acetyl-coenzyme A carboxylase gene expression and preadipocyte differentiation. Mol Endocrinol 2:395-403
34. Doerrler W, Feingold KR, Grunfeld C (1994) Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6:478-484
35. Memon RA, Fuller J, Moser AH, Smith PJ, Feingold KR, Grunfeld C (1998) in vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines. Am J Physiol 38:E64-E72
36. Lopezsoriano J, Llovera M, Carbo N, Garciamartinez C Lopezsoriano FJ, Argiles JM (1997) Lipid metabolism in tumour-bearing mice - studies with knockout mice for tumour necrosis factor receptor 1 protein. Mol Cell Endocrinol 132:93-99
37. Sethi J, Hotamisligil G (1998) Unpublished data
38. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410
39. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie EJ, Londos C (1991) Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of the lipid storage droplets. J Biol Chem 266:11341-11346
40. Hadri KE, Courtalon A, Gauthereau X, Chambaut-Guerin AM, Pairault J, Feve B (1997) Differential regulation by tumor necrosis factor-alpha of betal-, beta2-, and beta3-adrenoreceptor gene expression in 3T3-F442A adipocytes. J Biol Chem 272:24514-24521
41. McCall X, Tuckey JA, Parry BR (1992) Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 79:1361-1363
42. van der Poll T, Romijn JA, Endert E, B JJJ, Buller HR, S HR, S HP (1991) Tumor necrosis factor mimics the metabolic responses to acute infection in healthy humans. Am J Physiol 261:E457-E465
43. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Hendon DN, Wolfe RR (1989) Differentiation between septic and postburn insulin resistance. Metabolism 38:983-989
44. Ikezu T, Okamoto T, Yonezawa K, Tompkins RG, Martyn JA (1997) Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J Biol Chem 272:25289-25295
45. Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J (1998) Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes - implication of the P80 tumor necrosis factor receptor. Diabetes 47:515-522
46. Lang CH, Dobrescu C, Bagby GJ (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52
47. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
48. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858
49. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesityinduced insulin resistance. Science 271:665-668
50. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91
51. Spiegelman BM, Hotamisligil GS (1993) Through thick and thin: wasting, obesity, and TNF alpha. Cell 73:625-627
52. Hoffmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM (1994) Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270
53. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415
54. Yamakawa T, Tanaka S, Yamakawa Y, Kiuchi Y, Isoda F, Kawamoto S, Okuda K, Sekihara H (1995) Augmented production of tumor necrosis factor-alpha in obese mice. Clin Immunol Immunopathol 75:51-56
55. Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS (1995) Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44:1266-1273
56. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola LM (1997) Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 272:8830-8835
57. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119
58. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA (1996) The expression of TNFα by human muscle: Relationship to insulin resistance. J Clin Invest 97:1111-1116
59. Pfeiffer A, Janott J, Mohlig M, Ristow M, Rochlitz H, Busch K, Schatz H, Schifferdecker E (1997) Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II Diabetes Mellitus. Horm Metab Res 29:111-114
60. Mantzoros CS, Moschos S, Avramopoulos 1, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N, Flier JS (1997) Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab 82:3408-3413
61. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y (1998) Serum levels of tumor necrosis factor-alpha are increased in obese Patients with Non-insulin-Dependent Diabetes Mellitus. J Clin Endocrinol Metab 83:859-862
62. Winkler G, Salamon F, Salamon D, G. S, Simon K, Cseh K (1998) Elevated serum tumor necrosis factor-alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 41:860-861
63. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H (1998) Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vase Biol 18:1199-1202
64. Desfaits AC, Serri O, Renier G (1998) Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 21:487-493
65. Dandona P, Weinstock R, Thusu K, Abdelrahman E, Aljada A, Wadden T (1998) Tumor necrosis factor-alpha in sera of obese patients - fall with weight loss. J Clin Endocrinol Metab 83:2907-2910
66. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H, Serizawa N (1994) Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135:2279-2282
67. Szalkowski D, White-Carrington S, Berger J, Zhang B (1995) Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-LI cells. Endocrinology 136:1474-1481
68. Solomon SS, Mishra SK, Cwik C, Rajanna B, Postlethwaite AE (1997) Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells. Horm Metab Res 29:379-382
69. Murase K, Odaka H, Suzuki M, Tayuki N, Ikeda H (1998) Pioglitazone time-dependently reduces tumour necrosis factor-alpha level In muscle and improves metabolic abnormalities in Wistar fatty rats. Diabetologia 41:257-264
70. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379
71. Cheung AT, Ree D, Rolls JK, Fuselier J, Coy DH, Bryerash M (1998) An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNFα)-induced insulin resistance - Evidence for a differential regulation of insulin signaling by TNFα. Endocrinology 139:4928-4935
72. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R (1996) Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885
73. Uysal KT, Wiesbrock SM, Hotamisligil GS (1998) Functional analysis of TNF receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139:4832-4838
74. Schreyer SA, Chua Jr. SC, LeBoeuf RC (1998) Obesity and diabetes in TNF alpha and receptor deficient mice. J Clin Invest 102:402-411.
75. Long SD, Pekala PH (1996) Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT 4 gene transcription in 3T3-LI adipocytes. Biochem J 319:179-184
76. Stephens JM, Pekala PH (1991) Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-LI adipocytes by tumor necrosis factor-alpha. J Biol Chem 266:21839-21845
77. Kahn BB (1998) Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell 92:593-596
78. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A (1995) Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780-23784
79. Paz K, Hemi R, Leroith D, Karasik A, Elhanany E, Kanety H, Zick Y (1997) Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911-29918
80. Guo D, Donner D (1996) Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate-1 to phosphatidylinositol 3-kinase in 3T3-LI adipocytes. J Biol Chem 271:615-618
81. Kellerer M, Mushack J, Mischak H, Haring HU (1997) Protein kinase C (PKC) epsilon enhances the inhibitory effect of TNF alpha on insulin signaling in HEK293 cells. FEBS Lett 418:119-122
82. Kellerer M, Mushack J, Seffer E, Mischak H, Ullrich A, Haring HU (1998) Protein Kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (Hek 293 Cells). Diabetologia 41:833-838
83. Guy GR, Cao X, Chua SP, Tan YH (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267:1846-1852
84. Kroder G, Kellerer M, Bossenmaier B, Muhlhofer A, Haring H-U (1995) TNF-alpha induced insulin receptor inhibition depends on phosphatase activation. Diabetes 44:264A
85. Ahmad F, Goldstein BJ (1997) Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. J Cell Biochem 64:117-127
86. Donnelly R, Qu X (1998) Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications. Clin Expt Pharmacol Physiol 25:79-87
87. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM (1996) Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the P55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022
88. Kanety H, Hemi R, Papa MZ, Karasik A (1996) Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271:9895-9897
89. Wang C-N, O'Brien L, Brindley DN (1998) Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes 47:24-31
90. Lazono J, Berra E, Munico MM, Diaz-Meco MT, Domingues I, Sarz L, Moscat J (1994) Protein kinase C ζ (zeta) isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem 269:19200-19202
91. Muller G, Storz P, Bourteele S, Doppler H, Pfizenmaier K, Mischak H, Philipp A, Kaiser C, Kolch W (1998) Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J 17:732-742
92. Hannun YA (1994) The spingomyeline cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128
93. Law B, Rossie S (1995) The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2 ceramide. J Biol Chem 270:12808-12813
94. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Muhlhofer A, Berti L, Horikoshi R, Ullrich A, Haring H (1996) Tumor necrosis factor-alpha-and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97:1471-1477
95. Begum N, Ragolia L, Srinivasan M (1996) Effect of tumor necrosis factor-alpha on insulin-stimulated mitogen-activated protein kinase cascade in cultured rat skeletal muscle cells. Eur J Biochem 238:214-220
96. Valverde AM, Teruel T, Navarro P, Benito M, Lorenzo M (1998) Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinology 139:1229-1238
97. Stephens JM, Lee J, Pilch PF (1997) Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and Glut4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971-976
98. Halaas JL, Friedman JM (1997) Leptin and its receptor. J Endocrinol 155:215-216
99. Ur E, Grossman A, Despres JP (1996) Obesity results as a consequence of glucocorticoid induced leptin resistance. Horm Metab Res 28:744-747
100. Remesar X Rafecas I, Fernandez-Lopez JA, Alemany M (1997) Is leptin an insulin counter-regulatory hormone? FEBS Lett 402:9-11
101. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L (1998) A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688
102. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Freidman J, Feingold KR (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 97:2152-2157
103. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet D Jr, Flier JS, Lowell BB, Fraker DL, Alexander HR (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171-175
104. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782
105. Yamaguchi M, Murakami T, Tomimatsu T, Nishio Y, Mitsuda N, Kanzaki T, Kurachi H, Shima K, Aono T, Murata Y (1998) Autocrine inhibition of leptin production by tumor necrosis factor-alpha through TNF-alpha receptor 1 in vitro. Biochem Biophys Res Comm, 244:30-34
106. Ranganathan S, Maffei M, Kern PA (1998) Adipose tissue ob mRNA expression in humans: discordance with plasma leptin and relationship with adipose TNF alpha expression. J Lipid Res 39:724-730
107. Faggioni R, Fuller J, Moser A, Feingold KR, Grunfeld C (1997) LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am J Physiol 271:R181-186
108. Sethi JK, Uysal KT, Wiesbrock SM, Hotamisligil GS (1998) A novel role for tumor necrosis factor receptor 1 as regulator of leptin secretion. Int J Obes 21:880
109. Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P (1998) Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 41:65-71
110. Loskutoff DJ, Samad F (1998) The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vase Biol 18:1-6
111. Samad F, Yamamoto K, Loskutoff DJ (1996) Distribution and regulation of plasminogen activator inhibitor in murine adipose tissue in vivo. J Clin Invest 97:37-46
112. Bjorntorp P (1990) 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496
113. Torti FM, Torti SV, Larrick JW, Ringold GM (1989) Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol 108:1105-1113
114. Petruschke T, Hauner H (1993) Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 76:742-747
115. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM (1997) TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPAR gamma without effects on Pref-1 expression. Endocrinology 138:2776-2783
116. Sul HS, Smas CM (1993) Positive and negative regulators of adipocyte differentiation. J Nutr Biochem 4:554-562
117. Williams PM, Chang DJ, Danesh U, Ringold GM, Heller RA (1992) CAAT/enhancer binding protein expression is rapidly extinguished in TAI adipocyte cells treated with tumor necrosis factor alpha. Mol Endocrinol: 1135-1141
118. Loftus TM, Lane MD (1997) Modulating the transcriptional control of adipogenesis. Curr Opin Gen Dev 7:603-608
119. Fournier T, Fadok V, Henson PM (1997) Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Biol Chem 272:31065-31072
120. Navre M, Ringold GM (1988) A growth factor-repressible gene associated with protein kinase C-mediated inhibition of adipocyte differentiation. J Cell Biol 107:279-286
121. Sethi JK, Xu H, Uysal KT, Wiesbrock SM, Scheja L, Hotamisligil GS (1998) Establishment and characterization of preadipocyte cell lines from TNFR1, TNFR2 and TNFR1 and 2 knockout mice. J Interferon and Cytokine Res 18:A110
122. Urban (1986) Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83:5233-5237
123. Larrick JW, Write SC (1990) Cytotoxic mechanism of tumor necrosis factor. FASEB J 4:3215-3216
124. Prins JB, Walker NI, Winterford CM, Cameron DP (1994) Apoptosis of human adipocytes in vitro. Biochem Biophys Res Comm 201:500-507
125. Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O'Rahilly S, Walker NI, Cameron DP (1997) Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 46:1939-1944
126. Nisoli E, Briscini L, Tonello C, Degiulimorghen C, Carruba MO (1997) Tumor necrosis factor-alpha induces apoptosis in rat brown adipocytes. Cell Death Diff 4:771-778
127. Porras A, Alvarez AM, Valladares A, Benito M (1997) TNF-alpha induces apoptosis in rat fetal brown adipocytes in primary culture. FEBS Lett 416:324-328
128. Heller RA, Song K, Fan N, Chang DJ (1992) The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-56
129. Wallach D (1997) Cell death induction by TNF: a matter of self control. TIBS 22:107-109
130. Declercq W, Denecker G, Fiers W, Vandenabeele P (1998) Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF-receptor-associated factor binding domain of the TNF receptor 75. J Immunol 161:390-399
131. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne V, Culhane AC, Williams GT (1996) Apoptosis: molecular regulation of cell death. Eur J Biochem 237:884
132. Sovza SC, Devargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS (1998) Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-LI adipocytes. J Biol Chem 273:24665-24669